Importantly, diabetic retinopathy (DR) and nAMD share treatment options, as anti-VEGF intravitreal injections are used to treat both AMD-associated macular neovascularization (MNV) and diabetic macular oedema7,8. The gene discussed is VEGFA; the disease is diabetic retinopathy.